Ratcliffe Liam has filed 9 insider transactions across 4 companies since December 2022.
Most recent transaction: a grant/award of 15300 shares of OnKure Therapeutics, Inc. ($OKUR) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | OnKure Therapeutics, Inc. | $OKUR | Ratcliffe Liam | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 13,530,892 | 9999.99% | 0.11% |
| June 11, 2025 | Disc Medicine, Inc. | $IRON | Ratcliffe Liam | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 34,569,042 | 9999.99% | 0.03% |
| June 10, 2025 | Upstream Bio, Inc. | $UPB | Ratcliffe Liam | Not found | A | Stock Option (Right to Buy) | 17096 | $0.00 | 17,096.0000 | 53,640,895 | 9999.99% | 0.03% |
| Oct. 10, 2024 | Upstream Bio, Inc. | $UPB | Ratcliffe Liam | Not found | A | Stock Option (Right to Buy) | 17096 | $0.00 | 17,096.0000 | 0 | 9999.99% | 0.00% |
| June 26, 2024 | Climb Bio, Inc. | $CLYM | Ratcliffe Liam | Not found | A | Stock Option (Right To Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Disc Medicine, Inc. | $IRON | Ratcliffe Liam | Not found | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 9, 2023 | Disc Medicine, Inc. | $IRON | Ratcliffe Liam | Director | A | Stock Option (Right to Buy) | 7136 | $0.00 | 7,136.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | Climb Bio, Inc. | $CLYM | Ratcliffe Liam | Director | A | Stock Option (Right To Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2022 | Disc Medicine, Inc. | $IRON | Ratcliffe Liam | Director | A | Stock Option (Right to Buy) | 7000 | $0.00 | 7,000.0000 | 0 | 9999.99% | 0.00% |